US enzymes producer New England Biolabs has chosen MEPC’s
Milton Park in Oxfordshire as its first overseas development and manufacturing hub. The move follows the acquisition of UK-based Fluorogenics in May 2021, with a view to broadening the company's
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE.
Register
Find Out More